Deepa Dash

Neurologist with special interest in Movement disorders and epidemiology
Fellowship in Movement disorders,advanced device-aided therapies,Mc Master Clinical Epi

[Deepa Dash @DeepaDash4]

Another publication in the Movement Disorders Journal, culmination of my fellowship work

[Deepa Dash @DeepaDash4]

Privileged to have worked with a great team of MDS members and being given the opportunity to be the first author of the International Parkinson and Movement Disorder Society Evidence-Based Medicine Review for tretament of Essential tremor

[Deepa Dash @DeepaDash4]

@batraatulonc @dradhiparora @DrRishabhOnco @hema_oncologist Great work Atul

[Deepa Dash @DeepaDash4]

Grateful again for the opportunity to present invited presentation in MDS congress 2025 with the stalwarts of field Dr Titulaer and chaired by Dr Balint.

[Deepa Dash @DeepaDash4]

Join us in the Spring" Living well with Parkinson's disease" on Apr 04 | 10:00 am - 3:00 pm
Tillsonburg, ON.Thank you to Parkinson Society Southwestern Ontario for hosting this insightful spring session and supporting individuals with Parkinson’s.

[Deepa Dash @DeepaDash4]

Great webinar about advances in Deep brain stimulation for People with Parkinon's https://t.co/XhbTCka96I

[WPC 2026 @WorldPDCongress]

The #wpc4yopd webinar series kicks off shortly with this talk on Parenting with Parkinson's.
Learn more: https://t.co/bZ0JGVwisz

This event is free, but registration is required.
Made possible with support from @MTPA_US.
#yopd #YoungOnsetParkinsons #Parkinsons

[Deepa Dash @DeepaDash4]

7 new Parkinson’s books in English, Italian and Dutch
https://t.co/WN16NrCO03

[Ottawa Methods Centre @OttMethodsCentr]

Today, we pause to honor the courage and sacrifice of those who have served our nation. Their dedication to peace and freedom will never be forgotten. In observance of Remembrance Day, our office is closed today and will reopen tomorrow.
#LestWeForget

[London Police Service ON @lpsmediaoffice]

On Remembrance Day, we pause to honour and remember the men and women who have served, and continue to serve Canada during times of war, conflict, and peace.

We recognize more than 2,300,000 Canadians who have served throughout our nation’s history and the more than 118,000 who made the ultimate sacrifice. Their devotion to our country will never be forgotten.

Join us today in observing a moment of silence at 11:00 am. #RemembranceDay #LestWeForget

[Deepa Dash @DeepaDash4]

Presented my first presentation in the Canadian Movement disorder meeting.Grateful for the opportunity and gratitude 🙏 to my mentor ;Tiago Mestre

[Deepa Dash @DeepaDash4]

https://t.co/tPkXQ0kabe

[Deepa Dash @DeepaDash4]

Dr. Deepa Dash - Sleeping with Parkinson’s: Tips for Improving Sleep Hyg... https://t.co/q0AcQONjMH via @YouTube

[Deepa Dash @DeepaDash4]

Fall Regional Parkinson’s Conference is set to take place at DoubleTree by Hilton on Saturday, October 26!

Join us for a fantastic lineup of presentations!
https://t.co/Hd37D9rG0p

[Prashanth L Kukkle @prashanthlk]

Abstracts portal opens for movement disorders society of India annual conference (#MDSICON) Great event to meet researchers and scholars to understand works & collaborate in India on #neurodegeneration #Tauopathies #synucleopathies. showcase and collaborate - Feb 2025
#Varanasi

[Michael Okun @MichaelOkun]

News flash: LSVT LOUD defeated NHS speech and language therapy for Parkinson's disease dysarthria (unclear, slow, slurred speech) in a new @bmj_latest randomized clinical trial by Sackley and colleagues.
Key Points:
- The authors tested LSVT LOUD vs NHS speech and language therapy vs control.
- It was pragmatic, multicenter, three arm, parallel group, unblinded, randomized and controlled.
- 388 folks enrolled.
- Self-reported voice handicap index used as primary outcome measure.
- The LSVT LOUD group had a lower voice handicap index score (improved).
- Most common adverse event was vocal strain.
- Folks followed for a year w/ benefit (intervention was only a few months).
My take: I am so glad to see data driven studies comparing different approaches to treatment of dysarthria in Parkinson's disease. We focus so much on drug development, however it is just as important we test Parkinson's behavioral and non-pharmacological interventions. Though more costly and associated with potential vocal strain, LSVT LOUD should be considered as an evidence-based option to address dysarthria in Parkinson’s disease. The authors felt that the vocal strain was treatable when it occured. One key issue will be developing person specific treatment plans for the boosters or re-interventions, to be sure the effect is maintained. https://t.co/AguWPJVIRa #parkinson #speechlanguagepathologist #SLP @FixelInstitute @ParkinsonDotOrg